Tahir Amin

Co-Founder & CEO / Initiative for Medicines, Access & Knowledge (I-MAK)

Tahir Amin is an attorney with more than 25 years of experience in intellectual property law.
He practiced as a solicitor of the Senior Courts of England and Wales with two of the leading IP firms in the United Kingdom, and served as in-house global IP counsel for multinational corporations.

In 2004, Amin moved to Bangalore, India, where he successfully helped pass a health-friendly patent law. That process led him to eventually co-found I-MAK, with the express purpose of re-shaping intellectual property laws and the political economy of 'innovation' to better serve the public. Amin’s approach to challenging patents has established a new model for treatment access, one that restores balance to the system by reshaping power structures and reining in corporate concentration.

He has served as legal advisor/consultant to many groups, including the European Patent Office, United Nations Environment Programme and World Health Organisation. He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and was a 2009 TED Fellow.



A question of equal vaccination

Tahir Amin, Mitbegründer & CEO, Initiative for Medicines, Access & Knowledge (I-MAK) I Prof. Dr. Gagandeep Kang, The Wellcome Trust Forschungslabor I Kai Kupferschmidt, Wissenschaftsjournalist, RiffReporter & Science Magazine

In Germany, the majority of the population has already been vaccinated against Covid-19. In other countries, only a few percent are. What steps are needed to protect us all? [...]